JP2019529579A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529579A5 JP2019529579A5 JP2019539736A JP2019539736A JP2019529579A5 JP 2019529579 A5 JP2019529579 A5 JP 2019529579A5 JP 2019539736 A JP2019539736 A JP 2019539736A JP 2019539736 A JP2019539736 A JP 2019539736A JP 2019529579 A5 JP2019529579 A5 JP 2019529579A5
- Authority
- JP
- Japan
- Prior art keywords
- heterocyclyl
- factor
- heteroalkyl
- alkynyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022193833A JP7825550B2 (ja) | 2016-10-03 | 2022-12-02 | 化合物、デバイスおよびその使用 |
| JP2025175101A JP2026016478A (ja) | 2016-10-03 | 2025-10-17 | 化合物、デバイスおよびその使用 |
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662403543P | 2016-10-03 | 2016-10-03 | |
| US201662403559P | 2016-10-03 | 2016-10-03 | |
| US201662403554P | 2016-10-03 | 2016-10-03 | |
| US201662403532P | 2016-10-03 | 2016-10-03 | |
| US201662403548P | 2016-10-03 | 2016-10-03 | |
| US201662403556P | 2016-10-03 | 2016-10-03 | |
| US201662403538P | 2016-10-03 | 2016-10-03 | |
| US62/403,532 | 2016-10-03 | ||
| US62/403,543 | 2016-10-03 | ||
| US62/403,559 | 2016-10-03 | ||
| US62/403,548 | 2016-10-03 | ||
| US62/403,556 | 2016-10-03 | ||
| US62/403,538 | 2016-10-03 | ||
| US62/403,554 | 2016-10-03 | ||
| US201662436832P | 2016-12-20 | 2016-12-20 | |
| US62/436,832 | 2016-12-20 | ||
| PCT/US2017/055001 WO2018067615A1 (en) | 2016-10-03 | 2017-10-03 | Compounds, devices, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193833A Division JP7825550B2 (ja) | 2016-10-03 | 2022-12-02 | 化合物、デバイスおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529579A JP2019529579A (ja) | 2019-10-17 |
| JP2019529579A5 true JP2019529579A5 (enExample) | 2020-11-12 |
| JP7626588B2 JP7626588B2 (ja) | 2025-02-04 |
Family
ID=60153463
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539736A Active JP7626588B2 (ja) | 2016-10-03 | 2017-10-03 | 化合物、デバイスおよびその使用 |
| JP2022193833A Active JP7825550B2 (ja) | 2016-10-03 | 2022-12-02 | 化合物、デバイスおよびその使用 |
| JP2025175101A Pending JP2026016478A (ja) | 2016-10-03 | 2025-10-17 | 化合物、デバイスおよびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193833A Active JP7825550B2 (ja) | 2016-10-03 | 2022-12-02 | 化合物、デバイスおよびその使用 |
| JP2025175101A Pending JP2026016478A (ja) | 2016-10-03 | 2025-10-17 | 化合物、デバイスおよびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11945786B2 (enExample) |
| EP (1) | EP3519399A1 (enExample) |
| JP (3) | JP7626588B2 (enExample) |
| KR (2) | KR20190092374A (enExample) |
| CN (1) | CN110036008A (enExample) |
| AU (3) | AU2017338824B2 (enExample) |
| CA (1) | CA3039203A1 (enExample) |
| MX (1) | MX2019003887A (enExample) |
| NZ (1) | NZ752250A (enExample) |
| SG (1) | SG11201902938TA (enExample) |
| WO (1) | WO2018067615A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190092374A (ko) | 2016-10-03 | 2019-08-07 | 시질론 테라퓨틱스, 인크. | 화합물, 장치, 및 이의 용도 |
| KR102230622B1 (ko) | 2017-11-24 | 2021-03-22 | 주식회사 엘지화학 | 포토레지스트 조성물 및 이를 이용한 포토레지스트 필름 |
| EP3759154A1 (en) | 2018-03-02 | 2021-01-06 | Sigilon Therapeutics, Inc. | Biocompatible hydrogel capsules and process for preparing same |
| US12605486B2 (en) | 2018-03-02 | 2026-04-21 | Sigilon Therapeutics, Inc. | Afibrotic compounds, devices, and uses thereof |
| BR112020020084A2 (pt) | 2018-04-04 | 2021-01-05 | Sigilon Therapeutics, Inc. | Partícula, preparação de uma pluralidade de partículas, método de preparação de uma partícula, e, composição de partículas. |
| KR102027693B1 (ko) * | 2018-04-30 | 2019-10-02 | (주)바이오액츠 | 벤젠환과 질소환을 포함하는 양친매성 화합물, 이의 제조방법 및 이를 포함하는 계면활성제 조성물 |
| UY38389A (es) | 2018-09-27 | 2020-04-30 | Sigilon Therapeutics Inc | Dispositivos implantables para terapia celular y métodos relacionados |
| AU2020248099A1 (en) * | 2019-03-27 | 2021-10-07 | Sigilon Therapeutics, Inc. | Compositions, devices and methods for treating Fabry disease |
| US20230123802A1 (en) * | 2019-03-27 | 2023-04-20 | Sigilon Therapeutics, Inc. | Compositions, devices, and methods for factor vii therapy |
| JP7259968B2 (ja) * | 2019-08-08 | 2023-04-18 | 東亞合成株式会社 | ２－シアノアクリレート化合物、及び、接着剤組成物 |
| WO2021062273A1 (en) * | 2019-09-27 | 2021-04-01 | Sigilon Therapeutics, Inc. | Methods of evaluating small molecule-modified polymers in compositions |
| US20230045277A1 (en) * | 2019-12-13 | 2023-02-09 | Sigilon Therapeutics, Inc. | Compounds, polymers, devices, and uses thereof |
| KR20250133471A (ko) | 2020-02-18 | 2025-09-05 | 길리애드 사이언시즈, 인코포레이티드 | 항바이러스 화합물 |
| TWI775313B (zh) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| CA3190778A1 (en) * | 2020-08-04 | 2022-02-10 | Sigilon Therapeutics, Inc. | Heteroaryl and heterocyclyl compounds |
| US12577200B2 (en) | 2020-09-18 | 2026-03-17 | Massachusetts Institute Of Technology | High-throughput method to rapidly add chemical moieties to a small molecule library |
| JP7563100B2 (ja) * | 2020-10-14 | 2024-10-08 | 東亞合成株式会社 | 仮固定用硬化性組成物、及び、仮固定方法 |
| JP7563101B2 (ja) * | 2020-10-14 | 2024-10-08 | 東亞合成株式会社 | 剥離性接着物製造用硬化性組成物、剥離性接着物、並びに、剥離方法 |
| KR102599566B1 (ko) * | 2020-11-27 | 2023-11-07 | 국방과학연구소 | 아크릴아미드 화합물 및 이의 유도체의 제조방법 |
| CN117042723A (zh) * | 2021-01-26 | 2023-11-10 | 西吉隆医疗股份有限公司 | 用于诱导抗原特异性免疫耐受的组合物、装置和方法 |
| US12378229B2 (en) | 2021-02-02 | 2025-08-05 | Liminal Biosciences Limited | GPR84 antagonists and uses thereof |
| CA3216162A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| AU2022328698B2 (en) | 2021-08-18 | 2025-02-20 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
| KR20240158222A (ko) * | 2021-12-30 | 2024-11-04 | 시질론 테라퓨틱스, 인크. | 변형된 다당류 중합체 및 이의 관련 조성물 및 방법 |
| US20230382875A1 (en) * | 2022-04-22 | 2023-11-30 | Promega Corporation | Compounds, compositions, and methods for isolation of nucleic acids |
| WO2023230524A1 (en) | 2022-05-25 | 2023-11-30 | Flagship Pioneering Innovations Vi, Llc | Compositions of secretory and/or catalytic cells and methods using the same |
| WO2023235884A1 (en) | 2022-06-03 | 2023-12-07 | Flagship Pioneering Innovations Vi, Llc | Compositions and methods |
| KR20250048240A (ko) * | 2022-07-01 | 2025-04-08 | 시질론 테라퓨틱스, 인크. | 공유 가교 결합된 다당류 및 이의 사용 방법 |
| CN119546647A (zh) | 2022-07-01 | 2025-02-28 | 西吉隆医疗股份有限公司 | 共价光交联多糖及其使用方法 |
| EP4602041A1 (en) * | 2022-10-14 | 2025-08-20 | Arcus Biosciences, Inc. | Hpk1 inhibitors and methods of use thereof |
| WO2024191428A1 (en) | 2023-03-14 | 2024-09-19 | Sigilon Therapeutics, Inc. | Hydrogel capsules comprising covalently photocrosslinked polysaccharides and islet cells |
| WO2025003984A1 (en) | 2023-06-29 | 2025-01-02 | Università Degli Studi del Piemonte Orientale “Amedeo Avogadro” | Inhibitors of heme oxygenase, compositions and uses thereof |
| CN117551113B (zh) * | 2023-11-07 | 2026-02-03 | 海南师范大学 | 一种1,2,3-三氮唑-生物素分子探针及其制备与应用 |
| WO2025117331A1 (en) | 2023-12-01 | 2025-06-05 | Eli Lilly And Company | Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2445568A1 (en) | 2001-04-27 | 2002-11-07 | Vertex Pharmaceuticals Incorporated | Triazole-derived kinase inhibitors and uses thereof |
| CN104744461A (zh) | 2001-09-21 | 2015-07-01 | 百时美施贵宝公司 | 含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂 |
| WO2003048081A2 (en) * | 2001-12-04 | 2003-06-12 | Bristol-Myers Squibb Company | Glycinamides as factor xa inhibitors |
| CN1720332A (zh) * | 2002-10-03 | 2006-01-11 | 洛桑生态综合技术联合公司 | O6－烷基鸟嘌呤－dna烷基转移酶的底物 |
| WO2007058646A1 (en) | 2005-11-15 | 2007-05-24 | Bristol-Myers Squibb Company | Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| PE20080906A1 (es) | 2006-08-17 | 2008-07-05 | Kemia Inc | Derivados heteroarilo como inhibidores de citocina |
| US20080242694A1 (en) * | 2006-09-18 | 2008-10-02 | D Sidocky Neil R | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| WO2010033701A2 (en) * | 2008-09-19 | 2010-03-25 | Genzyme Corporation | Inhibitors of sphingosine kinase 1 |
| JP5725475B2 (ja) | 2010-01-21 | 2015-05-27 | 公立大学法人名古屋市立大学 | ヒドロキサム酸誘導体及びそれを用いたｈｄａｃ８阻害剤 |
| CA2823837A1 (en) * | 2010-12-07 | 2012-06-14 | Yale University | Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same |
| DK3354665T5 (da) | 2011-06-02 | 2022-09-19 | Massachusetts Inst Technology | Modificerede alginater til celleindkapsling og celleterapi |
| ES2845473T3 (es) | 2013-03-14 | 2021-07-26 | Boehringer Ingelheim Int | (Bencil-ciano-metil)-amidas sustituidas de ácido 2-aza-biciclo[2.2.1]heptano-3-carboxílico inhibidores de la catepsina- C |
| ITTO20130356A1 (it) | 2013-05-03 | 2014-11-04 | Uni Degli Studi Del Piemonte Orientale Ame | Inibitori di nicotinamide fosforibosil transferasi, relative composizioni, prodotti ed usi |
| CN104844533B (zh) | 2014-02-17 | 2019-04-09 | 中国医学科学院药物研究所 | 含五元芳杂环的氨基丙二醇类化合物、其制备方法及其医药用途 |
| ES2748029T3 (es) | 2014-03-13 | 2020-03-12 | Univ Indiana Res & Tech Corp | Moduladores alostéricos de proteína núcleo de hepatitis B |
| CN104072478B (zh) | 2014-05-22 | 2016-06-01 | 大连理工大学 | 一类萘环4位含1,2,3-三唑的萘酰亚胺衍生物的合成及其应用 |
| KR102719485B1 (ko) * | 2014-08-01 | 2024-10-21 | 메사추세츠 인스티튜트 오브 테크놀로지 | 항-섬유 물질 및 응용을 위한 변형된 알기네이트 |
| EP3297693A1 (en) | 2015-05-17 | 2018-03-28 | Massachusetts Institute of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
| AU2016344041B2 (en) | 2015-11-01 | 2019-11-07 | Massachusetts Institute Of Technology | Materials with improved properties |
| NZ742800A (en) | 2015-11-01 | 2019-03-29 | Massachusetts Inst Technology | Modified alginates for anti-fibrotic materials and applications |
| KR20190092374A (ko) | 2016-10-03 | 2019-08-07 | 시질론 테라퓨틱스, 인크. | 화합물, 장치, 및 이의 용도 |
| EP3687580A1 (en) | 2017-09-27 | 2020-08-05 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising active cells |
-
2017
- 2017-10-03 KR KR1020197012357A patent/KR20190092374A/ko not_active Ceased
- 2017-10-03 JP JP2019539736A patent/JP7626588B2/ja active Active
- 2017-10-03 EP EP17787728.9A patent/EP3519399A1/en active Pending
- 2017-10-03 CA CA3039203A patent/CA3039203A1/en active Pending
- 2017-10-03 KR KR1020237038602A patent/KR20230156818A/ko active Pending
- 2017-10-03 MX MX2019003887A patent/MX2019003887A/es unknown
- 2017-10-03 AU AU2017338824A patent/AU2017338824B2/en active Active
- 2017-10-03 SG SG11201902938TA patent/SG11201902938TA/en unknown
- 2017-10-03 NZ NZ752250A patent/NZ752250A/en unknown
- 2017-10-03 CN CN201780074918.2A patent/CN110036008A/zh active Pending
- 2017-10-03 US US16/339,285 patent/US11945786B2/en active Active
- 2017-10-03 WO PCT/US2017/055001 patent/WO2018067615A1/en not_active Ceased
-
2022
- 2022-04-22 AU AU2022202684A patent/AU2022202684A1/en not_active Abandoned
- 2022-12-02 JP JP2022193833A patent/JP7825550B2/ja active Active
-
2023
- 2023-12-05 US US18/529,334 patent/US12522571B2/en active Active
-
2024
- 2024-04-26 AU AU2024202713A patent/AU2024202713A1/en active Pending
-
2025
- 2025-10-17 JP JP2025175101A patent/JP2026016478A/ja active Pending
- 2025-12-08 US US19/412,601 patent/US20260109677A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019529579A5 (enExample) | ||
| US20230001396A1 (en) | Compositions and methods for controlled delivery and protection of therapeutic agents | |
| ES2872848T3 (es) | Agonistas selectivos de IL-2Rbeta en combinación con un anticuerpo anti-CTLA-4 o un anticuerpo anti-PD-1 | |
| US11701354B2 (en) | Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors | |
| EP3661560B1 (en) | Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors | |
| JP2021516271A5 (enExample) | ||
| US20190117561A1 (en) | Self-assembled nanoparticle releasing soluble microneedle structure and preparation method therefor | |
| US12226523B2 (en) | Method for preparing self-assembled nanoparticle releasing soluble microneedle structure | |
| JP2017511360A5 (enExample) | ||
| JP2017519781A5 (enExample) | ||
| JP2026016449A (ja) | 補体成分Ｃ５ａ受容体の非晶質形態 | |
| CN114641289A (zh) | 补体成分C5a受体的游离碱晶型 | |
| CA3241001A1 (en) | Methods and dosing regimens comprising a cdk2 inhibitor and a cdk4 inhibitor for treating cancer | |
| CN108884496A (zh) | Copanlisib生物标志物 | |
| AU2023282197B2 (en) | Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer | |
| WO2011135544A2 (en) | Methods and compositions for treating hepatitis with anti-cd3 immune molecule therapy | |
| CN109072307A (zh) | Copanlisib生物标志物 | |
| US20200281932A1 (en) | Formulations of copanlisib | |
| US20230405015A1 (en) | Substituted 3,6-dihydro-2h-1,3,4-oxadiazin-2-ones for the treatment of sarcoma | |
| CN113440533B (zh) | 水苏糖在制备用于治疗去势抵抗性前列腺癌药物中的应用 | |
| WO2023070000A1 (en) | Methods of use and administration of encapsulated cells | |
| JP2025506446A5 (enExample) | ||
| RU2018127494A (ru) | Химические соединения в качестве ингибиторов киназной активности | |
| JP2021503448A5 (enExample) | ||
| US20260115177A1 (en) | Medicinal products and methods for the alleviation of cancer immunothera-py-associated cytokine release syndrome |